ALOXI Helps Prevent CINV
ALOXI (palonosetron HCI) injection is an anti-nausea medication that may help prevent CINV when
you take chemotherapy. ALOXI is given as a single injection, often given through
the same intravenous (IV) line as your chemotherapy.
ALOXI can help prevent nausea and vomiting on the day of chemotherapy that is highly
likely to cause nausea and vomiting and up to 5 days following chemotherapy that
is moderately likely to cause nausea and vomiting.
If you are taking chemotherapy or are about to begin chemotherapy, spend a few moments
to learn about CINV. Most
importantly, talk with your
doctor about any symptoms of CINV you may be experiencing. Then ask what
ALOXI may do to help.
Indication in Adults
- ALOXI injection 0.25 mg/5 mL is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly
likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause
nausea and vomiting.
Indication in Pediatrics
- ALOXI injection 20 mcg/kg (max 1.5 mg) is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.
Important Safety Information
- ALOXI can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any
of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and
- The most common side effects of ALOXI in adults are headache and constipation
- Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan
to become pregnant or breastfeed
For more information about ALOXI, talk to your doctor or see full prescribing information (click here).
ALOXI is available by prescription only.
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit http://www.FDA.gov/medwatch or call